Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (19)

2024

  1. Definition and evolution of the concept of sarcopenia

    Nefrologia

2023

  1. Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

    Pharmaceuticals, Vol. 16, Núm. 4

  2. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

2022

  1. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination

    Frontiers in Immunology, Vol. 13

  2. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 11, pp. 2253-2263

  3. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 42, pp. 1-37

2021

  1. Control of phosphorus and prevention of fractures in the kidney patient

    Nefrologia, Vol. 41, Núm. 1, pp. 7-14

  2. FGF23: de la nefrología de salón a la cabecera del paciente

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 276-283

2019

  1. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study

    PLoS ONE, Vol. 14, Núm. 9

  2. Evaluating the optimal time for amikacin administration with respect to haemodialysis using an in vitro pharmacodynamic simulation against epidemic nosocomial OXA-48 producing Klebsiella pneumoniae ST405 strains

    Journal of Global Antimicrobial Resistance, Vol. 19, pp. 241-251

2018

  1. Incidence of hypersensitivity reactions during hemodialysis

    Kidney and Blood Pressure Research, Vol. 43, Núm. 5, pp. 1472-1478

  2. Pharmacological interactions of phosphate binders

    Nefrologia, Vol. 38, Núm. 6, pp. 573-578

  3. Position statement for the management of comorbidities in psoriasis

    Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 12, pp. 2058-2073

2017

  1. Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease

    Actas Dermo-Sifiliograficas

2016

  1. Enfermedad renal y psoriasis. ¿Una nueva comorbilidad?

    Actas Dermo-Sifiliograficas

  2. Kidney Disease and Psoriasis. A New Comorbidity?

    Actas Dermo-Sifiliograficas

2014

  1. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

2008

  1. Occult hepatitis C virus infection among hemodialysis patients

    Journal of the American Society of Nephrology, Vol. 19, Núm. 12, pp. 2288-2292

2005

  1. Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: Results of a Spanish survey

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 6, pp. 335-339